AU3192393A - Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy - Google Patents

Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy

Info

Publication number
AU3192393A
AU3192393A AU31923/93A AU3192393A AU3192393A AU 3192393 A AU3192393 A AU 3192393A AU 31923/93 A AU31923/93 A AU 31923/93A AU 3192393 A AU3192393 A AU 3192393A AU 3192393 A AU3192393 A AU 3192393A
Authority
AU
Australia
Prior art keywords
pyridobenzodiazepiones
axial myopia
myopia therapy
selective antimuscarinic
antimuscarinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31923/93A
Inventor
Pierre Mallorga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3192393A publication Critical patent/AU3192393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU31923/93A 1992-01-21 1993-01-20 Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy Abandoned AU3192393A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82349592A 1992-01-21 1992-01-21
US823495 1992-01-21

Publications (1)

Publication Number Publication Date
AU3192393A true AU3192393A (en) 1993-07-22

Family

ID=25238929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31923/93A Abandoned AU3192393A (en) 1992-01-21 1993-01-20 Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy

Country Status (10)

Country Link
EP (1) EP0556947A1 (en)
JP (1) JPH0742231B2 (en)
CN (1) CN1074606A (en)
AU (1) AU3192393A (en)
CA (1) CA2087510A1 (en)
IL (1) IL104409A0 (en)
MX (1) MX9300250A (en)
TW (1) TW222583B (en)
WO (1) WO1993013777A1 (en)
ZA (2) ZA93384B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
WO1998030900A2 (en) * 1997-01-06 1998-07-16 Klaus Trier Aps Screening method for compounds active in treating myopia and hypermetropia
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
WO2016171282A1 (en) * 2015-04-24 2016-10-27 学校法人慶應義塾 Agent for preventing myopia and myopia progression inhibitor
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US10845622B2 (en) 2015-09-15 2020-11-24 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
CN106526888B (en) 2015-09-15 2019-08-06 星欧光学股份有限公司 contact lens product
CN115414357B (en) * 2022-08-30 2023-09-22 天津医科大学眼科医院 Application of amide compound in preparation of medicaments for preventing and treating myopia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212742B (en) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa DIBENZO DERIVATIVES [1,4] PYRID DIAZEPINONIC [1,4] BENZODIAZEPINONIC, PYRID [1,5] BENZODIAZEPINONIC AND THEIR PHARMACOLOGICAL ACTIVITY
JP3165436B2 (en) * 1989-06-21 2001-05-14 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア Treatment and control of eye development

Also Published As

Publication number Publication date
IL104409A0 (en) 1993-05-13
ZA93384B (en) 1993-08-23
CA2087510A1 (en) 1993-07-22
WO1993013777A1 (en) 1993-07-22
JPH0742231B2 (en) 1995-05-10
ZA93374B (en) 1993-08-23
CN1074606A (en) 1993-07-28
MX9300250A (en) 1993-07-01
TW222583B (en) 1994-04-21
JPH06206820A (en) 1994-07-26
EP0556947A1 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
AU2464195A (en) Method of performing laser therapy
AU3278995A (en) Catheter sleeve and method of use
AUPN698495A0 (en) Improved therapeutic formulation and method
AU3497395A (en) Irradiation catheter and method of use
AU643420B3 (en) Improved wheel and method of forming same
AU7014296A (en) Method and apparatus for alleviating cardioversion shock pain
AU5163193A (en) Method and apparatus for corneal reprofiling
AU4139196A (en) Method and composition for antiviral therapy
AU2358895A (en) Medical electrode and method
AU2469795A (en) Liquid treatment method and system
AU7968894A (en) Pacemaker and method of fabrication
AU5218593A (en) Method of milling
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
AU2952192A (en) Highlighting preparation and method of use
AU3192393A (en) Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy
AU5955094A (en) Methods and compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections
AU7065694A (en) Catheter and method of use thereof
AU6253294A (en) Method and apparatus for enabling intravenous therapy
AU4805093A (en) Methods for treatment of enzyme preparations
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU1293195A (en) Composition and method for sewage treatment using fungal and bacterial enzymes
AU3320595A (en) Workpiece placement system and method of use
AU2992295A (en) Therapeutic method and compounds of use therein
AU5149793A (en) Method of preparing aminoalkylhydantoins and aminoalkyl-alpha-aminoacids
AU7871494A (en) Sinus preference method and apparatus for cardiac pacemakers